Perazole

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Perazole

What is Perazole?

Perazole is a pharmacological agent belonging to the class of medications known as proton pump inhibitors (PPIs). It is primarily utilized to manage conditions associated with excessive gastric acid production. By targeting the enzymatic pathways within the stomach lining, it helps to regulate the internal environment of the digestive system.

Mechanism of Action

The medication works by inhibiting the H^+/K^+-ATPase enzyme system, commonly referred to as the gastric acid pump. This system is located within the parietal cells of the stomach wall and represents the final stage of acid secretion. By blocking this mechanism, the medication effectively reduces the volume of hydrochloric acid released into the stomach lumen.

Primary Applications

Perazole is typically employed in the management of several acid-related gastrointestinal issues, including:

  • Gastroesophageal Reflux Disease (GERD): A condition where stomach acid frequently flows back into the esophagus, causing irritation of the esophageal lining.
  • Gastric and Duodenal Ulcers: The medication aids in the environment necessary for the natural resolution of sores that develop on the inner lining of the stomach or the upper part of the small intestine.
  • Zollinger-Ellison Syndrome: A rare condition characterized by the formation of tumors in the pancreas or duodenum that stimulate the overproduction of gastric acid.
  • Erosive Esophagitis: Helping to manage inflammation and damage to the esophagus resulting from chronic acid exposure.

By controlling acid levels, the medication assists in stabilizing the mucosal lining of the upper gastrointestinal tract and preventing further acid-induced irritation.

Regulatory References

  1. Omeprazole (StatPearls - NIH)
  2. Omeprazole Delayed-Release Capsules FDA Label

What side effects are possible with Perazole?

Possible Side Effects and Safety Information

The safety profile for Perazole (Omeprazole) is structured by regulatory bodies to communicate documented adverse reactions based on their official frequency and the system-organ class affected. These classifications move from highly common events to rare but serious adverse reactions.


Adverse Reaction Classification

Side effects are categorized by frequency in official documents:

  • Common Reactions are frequently documented, and often involve the Gastrointestinal System (e.g., abdominal pain, diarrhea, constipation, flatulence, vomiting) and the Nervous System (headache).
  • Uncommon Reactions include effects such as insomnia, dizziness, increased liver enzymes, and skin rashes or pruritus.
  • Rare Reactions involve low-incidence events, including severe hypersensitivity reactions, taste disturbance, and blood disorders like leukopenia or thrombocytopenia.

Serious Adverse Reactions and Duration-Related Safety

Official labeling highlights rare but clinically significant adverse reactions. These include severe skin conditions, such as Stevens-Johnson Syndrome (SJS), and severe kidney issues like Acute Tubulointerstitial Nephritis (TIN). Treatment may also be associated with an increased risk of certain severe infections, such as Clostridium difficile-Associated Diarrhea (CDAD).

Safety notes tied to the duration of exposure are also documented:

Safety Note Context of Occurrence (Regulatory)
Bone Fracture Risk Associated with long-term and high-dose therapy (typically one year or more).
Hypomagnesemia Low serum magnesium levels reported with prolonged treatment.
Vitamin B12 Deficiency Noted with daily long-term use (e.g., longer than three years).

Constraints and Population Notes

The regulatory safety information notes the need to consider dose reduction in patients with severe hepatic impairment. Additionally, the medicine can interfere with certain diagnostic tests, such as those measuring Chromogranin A (CgA) levels, requiring temporary cessation of the drug before testing.

Overdose and Emergency Response

Perazole Overdose and when to seek help

In the event of exposure exceeding prescribed levels, immediate emergency medical attention must be sought. Official regulatory documentation states that overdosage with the active substance, Omeprazole, requires strictly symptomatic and supportive treatment.

Documented Manifestations

Regulatory reviews have documented a specific profile of clinical signs associated with Omeprazole overexposure, often involving doses up to 900 mg.

System Affected Documented Signs and Symptoms
Neurological Confusion, Drowsiness, Headache, Blurred vision
Systemic/Cardiac Tachycardia, Diaphoresis (increased sweating), Flushing
Gastrointestinal Nausea, Dry mouth

Required Management

Despite the presence of these manifestations, the officially reported outcomes indicate that symptoms are typically transient, and no serious clinical outcome has been reported. However, due to the nature of overexposure, clinical assessment is required.

It is formally stated that no specific antidote is known for Omeprazole overdosage. Furthermore, due to the substance being extensively protein bound, it is not readily dialyzable, which guides the required supportive measures. The primary response in any instance of overexposure is to contact emergency medical services for immediate care.

Therapeutic Uses of Perazole

What Perazole Treats: Main Uses and Benefits

Perazole (Omeprazole) is commonly used to help with symptomatic management across therapeutic domains involving certain distressing symptoms linked to heightened physiological activity. It is applied in contexts where supportive symptom management is appropriate. The medication is relevant for easing symptoms related to physical discomfort caused by conditions such as Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (gastric and duodenal ulcers), and Pathological Hypersecretory Conditions like Zollinger-Ellison Syndrome.

It plays a role in managing symptoms linked to potential ulcer development in patients taking high-risk medications, such as NSAIDs, and assists with the management of erosive damage in the esophagus. The primary intent is to address symptom clusters that may become intense or disruptive, as symptomatic relief helps patients cope more steadily.

Managing these symptoms helps improve day-to-day comfort and stability during symptomatic periods.

This provides supportive relief when symptoms interfere with routine activities. It contributes to easing the overall symptom load when used for conditions characterized by periods of heightened symptoms.


Key Facts: Symptom Relief Overview

Clinical Domain Symptom Axis Relieved Primary Therapeutic Benefit
GERD & Reflux Frequent Heartburn and Regurgitation Supports comfort and maintains functional stability
Ulcer Management Upper Abdominal Pain (PUD) Assists with symptomatic management during healing
Prophylaxis High-risk NSAID-associated discomfort Supports the management of symptoms during coexisting treatment

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Perazole (a name representing the proton pump inhibitor omeprazole) is commonly prescribed for adults and, in some formulations and doses, for children to treat conditions caused by excess stomach acid. These include gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal and gastric ulcers, and Zollinger-Ellison syndrome. It is also used in combination with antibiotics to treat ulcers caused by H. pylori bacteria.


Contraindications

Perazole is not suitable for all patients and should be avoided or used with extreme caution under the following circumstances:

Condition Reason for Caution or Avoidance
Allergy/Hypersensitivity Known allergy to omeprazole or any other proton pump inhibitor (PPI).
Concomitant Medications Use with certain antiretroviral drugs, such as nelfinavir or atazanavir.
Specific Symptoms Heartburn with symptoms mimicking a heart attack (e.g., chest pain spreading to the arm/jaw, sweating, lightheadedness).

Use with Caution

Your healthcare provider should be informed of any history of liver disease, as dose adjustments may be necessary. Caution is also advised in patients with osteoporosis or those at risk of bone fractures, as long-term or high-dose PPI use may increase fracture risk. Additionally, patients with a history of low magnesium levels (hypomagnesemia) or certain autoimmune conditions like lupus should be closely monitored.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Perazole (Omeprazole) focuses on two primary interaction types: those driven by altered gastric pH and those stemming from the inhibition of the metabolic enzyme CYP2C19.

Co-administration is formally contraindicated with Rilpivirine-containing products. Additionally, regulatory documents recommend avoiding use with the antivirals Nelfinavir and Atazanavir due to a documented decrease in their plasma concentrations. Use with the anti-platelet agent Clopidogrel is also discouraged due to the risk of diminished anti-platelet activity.

The reduction in stomach acidity alters the absorption of substances that require an acidic pH for dissolution, resulting in a documented decrease in the exposure of drugs such as Ketoconazole and Iron Salts. Conversely, the inhibition of CYP2C19 can lead to an officially documented increase in the systemic exposure of other medicines, including the immunosuppressant Tacrolimus and the anti-coagulants Warfarin and Phenytoin. This also necessitates monitoring of drugs like Cilostazol.

The herbal product St John’s Wort must be avoided. A non-drug constraint requires that Perazole be temporarily discontinued at least 14 days prior to specific diagnostic procedures, such as Chromogranin A (CgA) assessment.

Mechanism of Action

How Perazole Works

Perazole acts as a selective inhibitor primarily targeting the osteoclast cell, which is responsible for bone resorption. The mechanism of action begins with the direct binding to the enzyme farnesyl pyrophosphate synthase (FPPS), a critical enzyme within the osteoclast's mevalonate pathway.

The inhibition of FPPS activity subsequently impairs the overall mevalonate pathway, disrupting the synthesis of necessary lipids. This disruption specifically prevents the prenylation of small GTPases required for the function and survival of the osteoclast. The lack of functional GTPases ultimately blocks the formation and activation of the ruffled border, the specialized structure initiating bone degradation.

By disrupting this internal cellular machinery, Perazole promotes osteoclast apoptosis (programmed cell death). This cellular consequence results in a reduction in the rate of osteolysis (bone breakdown) and acts to modulate the overall skeletal remodeling cycle.

Dosage and Administration Information

How to Use Perazole

Perazole (Omeprazole) usage is governed by administration principles designed to ensure the medication's integrity and absorption. The primary method is oral administration using delayed-release capsules, tablets, or oral suspension. An Intravenous (IV) infusion is available for patients who are temporarily unable to take the medicine by mouth.

Administration Timing and Form

The medicine is typically taken once daily, with administration required before eating, often in the morning, to align with the physiological action of the active substance. Due to the specialized enteric coating that protects the medicine from stomach acid, the capsules or tablets must be swallowed whole with liquid and must not be chewed, crushed, or split. For patients with difficulty swallowing, the contents of the capsule may be opened and mixed with a small amount of soft food, such as applesauce, and consumed immediately.

Dosing Patterns and Duration

Dosing is determined by the specific use pattern. For common uses like duodenal ulcers or erosive esophagitis, the dose is generally 20 mg to 40 mg once daily. For Pathological Hypersecretory Conditions, the starting dose is 60 mg once daily; daily doses over 80 mg are typically divided and administered multiple times throughout the day. Treatment duration varies, with many courses lasting a defined short-term period of 4 to 8 weeks, while others, such as maintenance therapy for healed esophagitis or treatment of pathological hypersecretion, may continue long-term.

Special Administration Rules

Dose adjustment is generally not required for older adults or patients with renal impairment. However, dose reduction may be considered in cases of severe hepatic impairment. If a once-daily dose is missed, it should be taken as soon as remembered, but a double dose should never be taken at one time to compensate for the missed one.

Recent Clinical Evidence

Perazole: Recent Clinical Evidence

This section outlines the official research and study landscape for the active substance Omeprazole (marketed as Perazole), focusing on what kind of evidence exists, what outcomes were measured, and what remains uncertain.

Evidence for Symptom Relief and Healing

Research for Gastroesophageal Reflux Disease (GERD) has been applied in studies examining patient-reported changes in symptom intensity such as heartburn. These short-term Randomized Controlled Trials (RCTs) explored how symptoms evolved over time and monitored Health-related Quality of Life (QoL) measures. Trials reported measured gastric acid secretion levels during the study period, but research highlights a high potential for a placebo response in studies based on subjective symptom reporting.

For Erosive Esophagitis (EE) and Peptic Ulcer Disease (PUD), studies focused on objective measures. RCTs examined and recorded healing rates using endoscopic confirmation after the initial treatment phase. Research for ulcer prophylaxis explored whether there was a change in the frequency of Gastrointestinal (GI) bleeding events in patients taking high-risk medications, such as NSAIDs. When Omeprazole was studied with antibiotics, data showed patterns related to measured decreases in bacterial presence.

Evidence in Specific Populations and Research Gaps

Omeprazole was studied for use in pediatric populations, including infants and children. For the youngest age groups, the regulatory evidence uses extrapolation from adult trials, supplemented by limited pediatric data. Data for certain groups remain insufficient to draw broad conclusions across all pediatric age ranges.

The evidence highlights what is known and what is still uncertain. Long-term outcomes are not well established for all chronic endpoints. A key limitation is that comparative evidence is lacking for the isolated effect of Omeprazole in scenarios where it was often studied within multi-drug regimens.

Key Studies & References Omeprazole: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Perazole (FAQ)

Q: How long does the effect of Perazole last after taking it?

Perazole (Omeprazole) is a Proton Pump Inhibitor (PPI) that works to suppress stomach acid. It is typically taken once a day because it is designed to provide sustained acid suppression over the dosing interval, aligning with its typical once-daily use.

Q: What should I do if I forget to take a dose of Perazole?

Official guidance indicates that if one remembers a missed dose, it should be taken as soon as possible. However, regulatory instructions state that a double dose should never be taken at one time to compensate for a missed dose. One may resume the regular schedule for the next dose.

Q: Can Perazole be crushed or split if a person has trouble swallowing?

Due to the specialized enteric coating that protects the medicine, the delayed-release capsules or tablets must be swallowed whole and should not be crushed, split, or chewed. For patients with difficulty swallowing, official patient information states that the contents of the capsule may be opened and mixed with a small amount of non-acidic soft food, such as applesauce, for immediate consumption.

Q: Is Perazole typically taken once a day or multiple times?

Perazole is usually taken once a day. However, official dosing information shows that for specific conditions that require a higher total daily intake, such as Pathological Hypersecretory Conditions, daily doses over 80 mg are documented as being divided and administered multiple times throughout the day.

Q: Why do some people need to take Perazole for a long time?

The length of time Perazole is used is determined by the specific condition. While some treatments are for short periods (4–8 weeks), long-term use is documented for maintenance therapy for healed conditions like erosive esophagitis, or for chronic conditions like pathological hypersecretion.

Q: How does Perazole interact with birth control pills?

Official regulatory interaction profiles for Omeprazole do not list hormonal contraceptives (birth control pills) as a medication with a documented decrease in effectiveness. This indicates that regulatory documents do not list this as a specific interaction that changes the metabolism of oral contraceptives.

Q: Does Perazole affect your mood or energy levels?

Official regulatory documents list several central nervous system effects. Uncommon adverse reactions include dizziness and insomnia (difficulty sleeping). Other effects have been reported in post-marketing surveillance, such as anxiety and headache.

Q: What research has been done on Perazole's use in combination therapies?

Research has explored Omeprazole in combination with other medicines for specific outcomes. This includes studies with antibiotics to reduce bacterial presence in ulcers, and research for ulcer prophylaxis when taken with high-risk medications such as NSAIDs (Nonsteroidal Anti-inflammatory Drugs) to reduce Gastrointestinal (GI) bleeding events.

Q: Can Perazole be taken with over-the-counter pain relievers like ibuprofen?

Regulatory documents indicate that Omeprazole has been studied for prophylaxis (prevention) of GI bleeding events in patients taking high-risk medications like NSAIDs. These pain relievers are not listed among the specific co-administered drugs that cause documented changes in Omeprazole’s systemic exposure.

Q: Does taking Perazole require any specific blood tests?

Official safety notes state that long-term use may be associated with low serum magnesium levels (hypomagnesemia) and Vitamin B12 deficiency. Regulatory documents indicate that monitoring may be necessary for these conditions during prolonged treatment.

Q: Does Perazole cause weight gain or weight loss?

Weight changes were not noted as common side effects in the initial clinical trials for Omeprazole. However, weight gain has been reported in post-marketing surveillance, although official labeling does not specify the frequency or directly attribute the cause to the medicine.

Q: Can Perazole make you feel dizzy or drowsy?

Dizziness is officially documented as an uncommon adverse reaction. Drowsiness has also been reported through post-marketing surveillance. If these effects occur, regulatory guidance indicates that one should wait until they pass before driving or operating machinery.

Q: Is Perazole considered an antibiotic?

No, Perazole is not an antibiotic. It is officially classified as a highly specific Proton Pump Inhibitor (PPI), meaning its core function is to reduce stomach acid levels. It is sometimes used alongside antibiotics to help treat ulcers caused by H. pylori bacteria.

Q: What happens when you stop taking Perazole?

Official information indicates that abruptly discontinuing the medicine may lead to a rebound increase in stomach acid secretion, known as rebound hypersecretion. This is noted as a potential factor for the recurrence or worsening of symptoms.

Q: Can older people use Perazole safely?

Regulatory guidance states that dose adjustment is generally not required for older adults with normal kidney function. Caution is advised for all patients regarding the officially documented risks associated with long-term use, such as bone fracture.

Q: Are there any long-term effects associated with Perazole use?

Yes, official safety notes indicate that prolonged use (typically one year or more) is associated with an increased risk of bone fracture, low serum magnesium levels (hypomagnesemia), and Vitamin B12 deficiency.

Q: Is Perazole safe to take during pregnancy?

Omeprazole's FDA classification is Pregnancy Category C. This means animal studies show potential risk, but human studies are inadequate or lacking. Official guidance describes that use during pregnancy is typically assessed based on whether the potential benefit justifies the potential risk, given the category C classification.

Q: Does Perazole have any restrictions on driving while using it?

Omeprazole does not usually affect the ability to drive or use machinery. However, if uncommon side effects like dizziness or vision problems occur, regulatory guidance indicates that one should wait until these effects have passed before driving or using machinery.

Q: Can I drink alcohol while I am using Perazole?

Alcohol is not listed in official regulatory documents as having a direct pharmacological interaction with the way Omeprazole works. However, because alcohol consumption can increase stomach acid production, it may counteract the medicine's intended effect by increasing acid production.

Q: Are there any specific supplements that should be avoided with Perazole?

The herbal product St John's Wort is officially documented in regulatory information and must be avoided due to the potential for interaction.

Q: Does Perazole interact with caffeine?

Studies examining the influence of Omeprazole on metabolism have found that Omeprazole treatment does not affect the way caffeine is metabolized in the body.

Q: Is it possible to become dependent on Perazole?

Perazole is not classified as a controlled substance. However, discontinuing the drug may result in rebound acid hypersecretion and recurrence of symptoms upon discontinuation.

Q: What happens if I accidentally take two doses of Perazole?

Official guidance is explicit that if a once-daily dose is missed, a double dose should never be taken at one time to make up for it.

Q: How soon after starting Perazole should I expect to see results?

The medication may take between 1 and 4 days for the full acid-suppressing effect to be achieved. Although full relief may take a few days, some individuals may report feeling relief of symptoms within 24 hours.

Q: Is Perazole a controlled substance?

No, Perazole (Omeprazole) is an over-the-counter and prescription drug but is not classified as a controlled substance by the Food and Drug Administration (FDA).

Q: What should be included in a 'Medical Condition' list before starting Perazole?

Official information states that a healthcare provider should be informed of any history of liver disease, as dose adjustments may be necessary. Other conditions warranting caution include a history of osteoporosis or bone fracture risk, low magnesium levels (hypomagnesemia), or certain autoimmune conditions like lupus.

How should Perazole be stored and disposed of?

How to Store and Dispose of Perazole (Omeprazole)

The official labeling for Omeprazole mandates specific storage conditions to preserve the integrity of the delayed-release formulation.

Official Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, 20 to 25 C (68 to 77 F).
Protection Mandatory: Protect from moisture. Keep in the original container and ensure it is tightly closed.
Safety The medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Perazole should be discarded through an official drug take-back program or authorized collection site. If a take-back option is unavailable, the product may be mixed with an undesirable substance (such as dirt or coffee grounds), placed in a sealed container, and then thrown into the household trash, following regulator guidance. The product is not recommended for flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Perazole found in:

A-Z Index: